Notes:
Unfortunately, the combination therapy was inadequate to prevent stroke in high risk patients and this part of the study was stopped early by the safety monitoring committee. Results from the low risk aspirin cohort are not yet available.

Back

Contents

Part Three

Acknowledgments:
The content of this presentation was prepared by Dr. Gregory Albers of the Stanford Stroke Center.